This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
Standard submission dates apply for all listings, unless otherwise noted.
Guidance For Investigators Planning to Submit a Program Project Grant (P01)
Notice: Internet links not permitted in NIH Grant Applications
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
| Title | Announcement # | Expiration Date | Research Focus |
|---|---|---|---|
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems | PAR-20-155 (R01 Clinical Trial Optional) | 09/08/2022 |
|
| Administrative Supplement for Research on Dietary Supplements | PA-20-227 (Admin Supp-Clinical Trial Not Allowed) | 04/16/2023 |
|
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) | 10/11/2023 |
|
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-314 (UH3 Clinical Trials Not Allowed) | 10/11/2023 |
|
| Basic Research in Cancer Health Disparities | PAR-21-324 (R03 Clinical Trial Not Allowed) | 09/08/2024 |
|
| Basic Research in Cancer Health Disparities | PAR-21-322 (R01 Clinical Trial Not Allowed) | 09/08/2024 |
|
| Basic Research in Cancer Health Disparities | PAR-21-323 (R21 Clinical Trial Not Allowed) | 09/08/2024 |
|
| Biology of Bladder Cancer | PAR-19-184 (R21 Clinical Trial Optional) | 05/08/2022 |
|
| Biology of Bladder Cancer | PAR-19-183 (R01 Clinical Trial Optional) | 05/08/2022 |
|
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-21-035 (R01 Clinical Trial Required) | 01/08/2024 |
|
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research | PAR-19-113 (R01 Clinical Trial Optional) | 01/08/2022 |
|
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-19-325 (R01 Clinical Trial Optional) | 02/12/2022 |
|
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network | RFA-CA-21-047 (UG1 Clinical Trial Required) | 12/29/2021 |
|
| Co-infection and Cancer | PAR-20-062 (R01 Clinical Trial Not Allowed) | 01/08/2023 |
|
| Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network | RFA-CA-21-045 (U24 Clinical Trial Required) | 12/29/2021 |
|
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer | PAR-19-264 (R01 Clinical Trial Optional) | 12/11/2021 |
|
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-111 (R21 Clinical Trial Optional) | 01/08/2022 |
|
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-112 (R01 Clinical Trial Optional) | 01/08/2022 |
|
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer | PAR-20-081 (R21- Clinical Trial Not Allowed) | 04/02/2022 |
|
| Mechanisms of Disparities in Chronic Liver Diseases and Cancer | PAR-20-088 (R01- Clinical Trial Not Allowed) | 04/02/2022 |
|
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-331 (R01 Clinical Trial Optional) | 09/08/2024 |
|
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-332 (R21 Clinical Trial Not Allowed) | 09/08/2024 |
|
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain | PA-19-201 (R21 Clinical Trial Optional) | 05/08/2022 |
|
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain | PA-19-200 (R01 Clinical Trial Optional) | 05/08/2022 |
|
| Music and Health: Understanding And Developing Music Medicine | PAR-21-100 (R01 Clinical Trial Optional) | 02/06/2023 |
|
| Music and Health: Understanding And Developing Music Medicine | PAR-21-099 (R21 Clinical Trial Optional) | 02/17/2023 |
|
| NCI Clinical and Translational Exploratory/Developmental Studies | PAR-20-292 (R21 Clinical Trial Optional) | 07/21/2022 |
|
| NIH Research Project Grant | PA-20-185 (Parent R01 Clinical Trial Not Allowed) | 05/08/2023 |
|
| Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | NOT-CA-20-067 (R01 Clinical Trial Not Allowed) | 01/08/2023 |
|
| Notice of Special Interest: Advancing the Science of Geriatric Palliative Care | NOT-AG-20-041 | 09/08/2023 |
|
| Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications | NOT-DK-20-001 | 01/08/2023 |
|
| Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants | NOT-CA-21-070 | 05/16/2023 |
|
| Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) | NOT-CA-20-031 | 01/08/2022 |
|
| Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia | NOT-CA-21-057 | 05/08/2023 |
|
| Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults | NOT-CA-21-108 | 05/08/2023 |
|
| Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers | NOT-CA-21-028 | 01/08/2024 |
|
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | 05/08/2023 |
|
| Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones | NOT-DK-20-002 | 01/08/2023 |
|
| Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit | PAR-21-335 (U24 Clinical Trial Not Allowed) | 06/12/2024 |
|
| Pancreatic Cancer Detection Consortium: Research Units | PAR-21-334 (U01 Clinical Trial Optional) | 06/12/2024 |
|
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | PAR-20-053 (R01 Clinical Trial Not Allowed) | 01/08/2023 |
|
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions | PAR-20-266 (R61/R33 Clinical Trial Optional) | 06/20/2023 |
|
| Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network | RFA-CA-21-046 (UG1 Clinical Trial Required) | 12/29/2021 |
|
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-20-074 (R01 Clinical Trial Not Allowed) | 10/29/2022 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 (R01 Clinical Trial Not Allowed) | 09/08/2022 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-277 (R21 Clinical Trials Not Allowed) | 09/08/2022 |
|
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-039 (R01 Basic Experimental Studies with Humans Required) | 12/29/2023 |
|
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-038 (R01 Clinical Trial Not Allowed) | 12/29/2023 |
|
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research | PAR-21-330 (U01 Clinical Trial Not Allowed) | 10/12/2024 |
|
| Validation Studies of Analytical Methods for Dietary Supplement Constituents | PA-20-252 (Admin Supp - Clinical Trial Not Allowed) | 04/16/2022 |
|